Cite
HARVARD Citation
Colinet, B. et al. (2021). Osimertinib in patients with advanced/metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer - the Belgian ASTRIS data. Acta clinica belgica. 76 (3), pp. 224-231. [Online].